Perceptive Advisors - VERONA PHARMA PLC ownership

VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 41 filers reported holding VERONA PHARMA PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of VERONA PHARMA PLC
ValueSharesWeighting
Q3 2023$65,317,311
-30.2%
4,007,197
-18.2%
2.18%
-19.6%
Q2 2023$93,630,032
+70.6%
4,897,116
+79.1%
2.71%
+67.2%
Q1 2023$54,894,503
-57.0%
2,733,790
-44.0%
1.62%
-54.7%
Q4 2022$127,533,187
+147.2%
4,880,719
-3.3%
3.58%
+139.2%
Q3 2022$51,583,000
+322.3%
5,047,264
+73.1%
1.50%
+290.9%
Q2 2022$12,214,000
-19.6%
2,915,146
-4.2%
0.38%
+26.0%
Q1 2022$15,191,000
-60.6%
3,044,303
-46.9%
0.30%
+2.4%
Q4 2021$38,540,000
+143.4%
5,735,020
+98.5%
0.30%
+29.1%
Q3 2021$15,831,000
-58.1%
2,888,889
-50.0%
0.23%
-6.1%
Q2 2021$37,786,000
+56.5%
5,777,778
+100.0%
0.24%
-19.7%
Q1 2021$24,151,000
+19.4%
2,888,8890.0%0.30%
+40.6%
Q4 2020$20,222,000
+12.2%
2,888,8890.0%0.22%
-17.5%
Q3 2020$18,027,000
+5772.0%
2,888,889
+12839.0%
0.26%
+3187.5%
Q2 2018$307,000
-72.7%
22,327
-60.2%
0.01%
-74.2%
Q1 2018$1,123,000
-52.9%
56,168
-71.9%
0.03%
-60.8%
Q4 2017$2,384,000
-61.2%
200,000
-50.0%
0.08%
-32.5%
Q3 2017$6,140,000
+163.4%
400,000
+100.0%
0.12%0.0%
Q2 2017$2,331,000200,0000.12%
Other shareholders
VERONA PHARMA PLC shareholders Q2 2022
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,111,112$4,656,00016.89%
Aisling Capital Management LP 1,332,485$5,583,0003.98%
Abingworth LLP 2,457,500$10,174,0003.26%
Samsara BioCapital, LLC 1,111,112$4,656,0001.24%
Vivo Capital, LLC 2,749,918$11,522,0001.16%
NEA Management Company, LLC 5,108,563$21,405,0001.10%
Fairmount Funds Management LLC 926,602$3,882,0000.89%
RA Capital Management 5,100,000$21,369,0000.57%
Orbimed Advisors 5,694,841$23,861,0000.43%
Perceptive Advisors 2,915,146$12,214,0000.38%
View complete list of VERONA PHARMA PLC shareholders